Abrdn Healthcare Investors (NYSE:HQH - Get Free Report) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 55,800 shares, an increase of 26.2% from the March 31st total of 44,200 shares. Based on an average daily volume of 201,500 shares, the short-interest ratio is presently 0.3 days. Approximately 0.1% of the company's stock are sold short.
Abrdn Healthcare Investors Price Performance
Shares of NYSE HQH traded up $0.21 during trading on Friday, hitting $16.28. 134,542 shares of the company traded hands, compared to its average volume of 185,614. The business's fifty day moving average is $16.01 and its 200 day moving average is $16.98. Abrdn Healthcare Investors has a fifty-two week low of $13.77 and a fifty-two week high of $19.79.
Abrdn Healthcare Investors Cuts Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Friday, February 21st were paid a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a yield of 14.00%. The ex-dividend date was Friday, February 21st.
Institutional Investors Weigh In On Abrdn Healthcare Investors
A number of hedge funds have recently added to or reduced their stakes in HQH. FNY Investment Advisers LLC bought a new position in shares of Abrdn Healthcare Investors in the 4th quarter worth $48,000. Atomi Financial Group Inc. lifted its stake in shares of Abrdn Healthcare Investors by 7.2% in the fourth quarter. Atomi Financial Group Inc. now owns 24,920 shares of the financial services provider's stock valued at $400,000 after buying an additional 1,680 shares in the last quarter. Kingswood Wealth Advisors LLC lifted its stake in shares of Abrdn Healthcare Investors by 63.7% in the fourth quarter. Kingswood Wealth Advisors LLC now owns 54,531 shares of the financial services provider's stock valued at $875,000 after buying an additional 21,212 shares in the last quarter. Absolute Investment Advisers LLC bought a new stake in shares of Abrdn Healthcare Investors during the fourth quarter worth about $1,786,000. Finally, Stratos Wealth Partners LTD. acquired a new stake in shares of Abrdn Healthcare Investors in the 4th quarter worth about $187,000. Institutional investors and hedge funds own 32.60% of the company's stock.
About Abrdn Healthcare Investors
(
Get Free Report)
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Abrdn Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Abrdn Healthcare Investors wasn't on the list.
While Abrdn Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
